communityresourcesplanning.com → mean stock → short term sound → what is pseudogout
Posted on by Cody Becker

What Is Pseudogout

Close-up of a knee joint showing inflammation and crystal deposits under microscopic view

Pseudogout is a type of inflammatory arthritis triggered by the deposition of calcium pyrophosphate dihydrate (CPPD) crystals in joints, causing episodes of sudden pain, swelling, and stiffness. Unlike gout, which results from uric acid crystals, pseudogout stems from calcium-based crystals and often affects larger joints like the knees, wrists, and hips.

These crystals form when calcium and pyrophosphate levels in synovial fluid become imbalanced. The immune system responds aggressively to their presence, releasing inflammatory chemicals that damage joint tissue. Episodes typically last days to weeks and may recur unpredictably. Pseudogout is not rare-it affects about 1 in 100 adults over age 60, according to the American College of Rheumatology.

Diagnosis requires joint fluid analysis. A needle aspirates fluid from the swollen joint, and a polarized light microscope identifies the rhomboid-shaped CPPD crystals. These crystals appear positively birefringent-meaning they change color under specific lighting-distinguishing them from monosodium urate crystals seen in gout.

How Pseudogout Develops

The exact mechanism behind CPPD crystal formation remains unclear, but several factors increase risk. Age is the strongest predictor: most cases occur in people over 60. Genetic mutations in the ANKH gene disrupt phosphate transport, elevating intracellular pyrophosphate levels. This mutation is linked to familial forms of pseudogout, though it's rare.

Other triggers include joint trauma, surgery, dehydration, and metabolic disorders such as hypothyroidism, hyperparathyroidism, and hemochromatosis. A 2020 study in Rheumatology found that patients with hemochromatosis had a 3.7-fold higher risk of developing pseudogout compared to controls.

Once crystals deposit in cartilage or synovial fluid, they activate macrophages and neutrophils. These immune cells release interleukin-1β and tumor necrosis factor-alpha, driving acute inflammation. The result is a flare marked by redness, warmth, severe pain, and limited motion-symptoms indistinguishable from acute gout without lab confirmation.

Types and Forms of Pseudogout

Pseudogout presents in four clinical patterns:

Form Description Prevalence
Acute monarticular Sudden onset in one joint, usually the knee. Most common presentation. ~60%
Chronic arthropathy Slow progression of joint damage with recurrent flares. Often misdiagnosed as osteoarthritis. ~20%
Systemic illness Flares involving multiple joints with fever and elevated CRP. Can mimic septic arthritis. ~10%
Asymptomatic crystal deposition Crystals detected incidentally on imaging or fluid analysis, no symptoms. ~10%

One key distinction: pseudogout rarely causes tophi (visible crystal deposits under the skin), unlike chronic gout. This absence helps differentiate the two conditions clinically.

Where and Why It Occurs

Pseudogout most frequently targets large joints. The knee is involved in 70% of acute cases, followed by the wrist (15%), shoulder (8%), and hip (5%). The hip is particularly notable because early pseudogout flares are often mistaken for avascular necrosis or infection due to similar MRI findings.

Joint degeneration increases susceptibility. Cartilage breakdown releases stored pyrophosphate, creating a feedback loop. A 2018 study in Arthritis & Rheumatology showed that patients with knee osteoarthritis were 4.2 times more likely to have CPPD crystals visible on ultrasound than those without.

Environmental stressors play a role too. Dehydration during illness or post-surgical recovery can concentrate synovial fluid, promoting crystal nucleation. Iatrogenic causes-such as corticosteroid injections or joint manipulation-have also been linked to flare-ups in susceptible individuals.

Common Confusions and Misconceptions

Pseudogout is frequently mistaken for gout, especially in older adults with comorbidities. Both cause intense joint pain and swelling, and both are diagnosed via joint aspiration. However, the crystals differ: gout crystals are needle-shaped and negatively birefringent; pseudogout crystals are rhomboid and positively birefringent.

A major error is assuming that pseudogout only occurs in elderly people. While prevalence rises sharply after age 60, younger adults with genetic predisposition or metabolic disease can develop it. One patient I evaluated at a university clinic was 38 years old with undiagnosed hemochromatosis and recurrent wrist flares. His initial diagnosis was rheumatoid arthritis until fluid analysis revealed CPPD crystals.

Another misconception is that pseudogout always causes severe pain. Some patients report mild discomfort or none at all. Asymptomatic deposition is common-up to 30% of people with detectable crystals never experience a flare. This makes screening high-risk populations challenging.

Real-World Example: Diagnosing a Knee Flare

A 72-year-old woman presented with sudden left knee swelling, warmth, and inability to bear weight. She had no history of gout or recent trauma. Blood tests showed a normal white count but elevated CRP (68 mg/L). X-ray revealed chondrocalcinosis-calcification in the meniscus and articular cartilage-suggesting CPPD disease.

Joint aspiration confirmed the diagnosis: 1 mL of cloudy fluid with 10,000 WBCs/mL and numerous rhomboid-shaped crystals under polarized light. No monosodium urate crystals were present. She received a single intra-articular triamcinolone injection and oral colchicine (0.6 mg twice daily for five days). Symptoms resolved within 72 hours.

This case illustrates the diagnostic pathway: clinical suspicion based on age and joint pattern, radiographic evidence of calcification, and definitive confirmation via microscopy. Without joint fluid analysis, the condition could have been mismanaged as infection or untreated osteoarthritis.

Key Takeaway

Pseudogout is a treatable form of crystal arthritis driven by calcium pyrophosphate dihydrate crystals. It affects joints in a predictable pattern, primarily the knee and wrist, and requires joint fluid analysis for accurate diagnosis. Distinguishing it from gout is critical-treatment differs, and mismanagement can delay recovery. Early recognition prevents long-term joint damage.

Understanding what is pseudogout enables timely intervention. With proper diagnosis and management, most patients achieve symptom relief and reduced flare frequency. Awareness of risk factors like age, metabolic disorders, and prior joint injury improves detection rates and outcomes.


Related Posts